Matthew Smalls joined the MirRam Group in 2017 and has become one of the foremost experts on pharmacy policy through his representation of the Pharmacists Society of the State of New York. Smalls previously served the state Senate Democratic Conference in several roles, including spec...
was abnormally high above 10,000 μg/L due to TDF administration, and Japanese HIV-1-positive patients who did not have obvi- ous renal dysfunction but were explained by physicians and pharmacists that they would be changed from TDF to TAF to prevent deterioration of renal function by con...
they really are asking this Court to transform their DEA registrations, which are premised on the idea that they’re actually practicing medicine, into licenses to, at their own subjective views, violate the general rule that drug pushing is illegal. They...